Brain-derived  ||| S:0 E:14 ||| JJ
neurotrophic  ||| S:14 E:27 ||| JJ
factor  ||| S:27 E:34 ||| NN
is  ||| S:34 E:37 ||| VBZ
expressed  ||| S:37 E:47 ||| VBN
in  ||| S:47 E:50 ||| IN
rat  ||| S:50 E:54 ||| NN
and  ||| S:54 E:58 ||| CC
human  ||| S:58 E:64 ||| JJ
placenta  ||| S:64 E:73 ||| NN
and  ||| S:73 E:77 ||| CC
its  ||| S:77 E:81 ||| PRP$
serum  ||| S:81 E:87 ||| JJ
levels  ||| S:87 E:94 ||| NNS
are  ||| S:94 E:98 ||| VBP
similarly  ||| S:98 E:108 ||| RB
regulated  ||| S:108 E:118 ||| VBN
throughout  ||| S:118 E:129 ||| IN
pregnancy  ||| S:129 E:139 ||| NN
in  ||| S:139 E:142 ||| IN
both  ||| S:142 E:147 ||| DT
species  ||| S:147 E:155 ||| JJ
Pregnancy  ||| S:155 E:165 ||| NNP
is  ||| S:165 E:168 ||| VBZ
characterized  ||| S:168 E:182 ||| VBN
by  ||| S:182 E:185 ||| IN
several  ||| S:185 E:193 ||| JJ
metabolic  ||| S:193 E:203 ||| JJ
changes  ||| S:203 E:211 ||| NNS
that  ||| S:211 E:216 ||| WDT
promote  ||| S:216 E:224 ||| VBP
fat  ||| S:224 E:228 ||| JJ
gain  ||| S:228 E:233 ||| NN
and  ||| S:233 E:237 ||| CC
later  ||| S:237 E:243 ||| RB
onset  ||| S:243 E:249 ||| VBN
of  ||| S:249 E:252 ||| IN
insulin  ||| S:252 E:260 ||| NN
resistance ||| S:260 E:270 ||| NN
.  ||| S:270 E:272 ||| .
As  ||| S:272 E:275 ||| IN
Brain-derived  ||| S:275 E:289 ||| JJ
neurotrophic  ||| S:289 E:302 ||| JJ
factor  ||| S:302 E:309 ||| NN
( ||| S:309 E:310 ||| -LRB-
BDNF ||| S:310 E:314 ||| NNP
)  ||| S:314 E:316 ||| -RRB-
decreases  ||| S:316 E:326 ||| VBZ
hyperglycaemia  ||| S:326 E:341 ||| VBN
and  ||| S:341 E:345 ||| CC
hyperphagia ||| S:345 E:356 ||| NN
,  ||| S:356 E:358 ||| ,
we  ||| S:358 E:361 ||| PRP
aimed  ||| S:361 E:367 ||| VBD
to  ||| S:367 E:370 ||| TO
investigate  ||| S:370 E:382 ||| VB
the  ||| S:382 E:386 ||| DT
potential  ||| S:386 E:396 ||| JJ
role  ||| S:396 E:401 ||| NN
of  ||| S:401 E:404 ||| IN
placental  ||| S:404 E:414 ||| NN
and  ||| S:414 E:418 ||| CC
circulating  ||| S:418 E:430 ||| VBG
BDNF  ||| S:430 E:435 ||| NNP
levels  ||| S:435 E:442 ||| NNS
in  ||| S:442 E:445 ||| IN
these  ||| S:445 E:451 ||| DT
pregnancy-related  ||| S:451 E:469 ||| JJ
metabolic  ||| S:469 E:479 ||| JJ
changes  ||| S:479 E:487 ||| NNS
in  ||| S:487 E:490 ||| IN
rats  ||| S:490 E:495 ||| NNS
and  ||| S:495 E:499 ||| CC
humans ||| S:499 E:505 ||| NNS
.  ||| S:505 E:507 ||| .
We  ||| S:507 E:510 ||| PRP
identified  ||| S:510 E:521 ||| VBD
the  ||| S:521 E:525 ||| DT
mRNA  ||| S:525 E:530 ||| JJ
and  ||| S:530 E:534 ||| CC
protein  ||| S:534 E:542 ||| NN
expression  ||| S:542 E:553 ||| NN
of  ||| S:553 E:556 ||| IN
placental  ||| S:556 E:566 ||| JJ
BDNF  ||| S:566 E:571 ||| NNP
and  ||| S:571 E:575 ||| CC
its  ||| S:575 E:579 ||| PRP$
receptor  ||| S:579 E:588 ||| NN
TrkB  ||| S:588 E:593 ||| NN
using  ||| S:593 E:599 ||| VBG
real-time  ||| S:599 E:609 ||| JJ
PCR ||| S:609 E:612 ||| NNP
,  ||| S:612 E:614 ||| ,
Western  ||| S:614 E:622 ||| JJ
blot  ||| S:622 E:627 ||| NN
and  ||| S:627 E:631 ||| CC
immunohistochemical  ||| S:631 E:651 ||| JJ
approaches  ||| S:651 E:662 ||| NNS
in  ||| S:662 E:665 ||| IN
both  ||| S:665 E:670 ||| DT
rat  ||| S:670 E:674 ||| NN
and  ||| S:674 E:678 ||| CC
humans ||| S:678 E:684 ||| NNS
.  ||| S:684 E:686 ||| .
Serum  ||| S:686 E:692 ||| NNP
BDNF  ||| S:692 E:697 ||| NNP
was  ||| S:697 E:701 ||| VBD
measured  ||| S:701 E:710 ||| VBN
by  ||| S:710 E:713 ||| IN
ELISA ||| S:713 E:718 ||| NNP
.  ||| S:718 E:720 ||| .
We  ||| S:720 E:723 ||| PRP
also  ||| S:723 E:728 ||| RB
did  ||| S:728 E:732 ||| VBD
a  ||| S:732 E:734 ||| DT
longitudinal  ||| S:734 E:747 ||| JJ
prospective  ||| S:747 E:759 ||| JJ
cohort  ||| S:759 E:766 ||| JJ
study  ||| S:766 E:772 ||| NN
in  ||| S:772 E:775 ||| IN
42  ||| S:775 E:778 ||| CD
pregnant  ||| S:778 E:787 ||| JJ
women  ||| S:787 E:793 ||| NNS
to  ||| S:793 E:796 ||| TO
assess  ||| S:796 E:803 ||| VB
BDNF  ||| S:803 E:808 ||| JJ
levels  ||| S:808 E:815 ||| NNS
and  ||| S:815 E:819 ||| CC
correlations  ||| S:819 E:832 ||| NN
with  ||| S:832 E:837 ||| IN
other  ||| S:837 E:843 ||| JJ
metabolic  ||| S:843 E:853 ||| JJ
parameters ||| S:853 E:863 ||| NNS
.  ||| S:863 E:865 ||| .
We  ||| S:865 E:868 ||| PRP
found  ||| S:868 E:874 ||| VBD
that  ||| S:874 E:879 ||| IN
BDNF  ||| S:879 E:884 ||| NNP
and  ||| S:884 E:888 ||| CC
TrkB  ||| S:888 E:893 ||| NNS
are  ||| S:893 E:897 ||| VBP
expressed  ||| S:897 E:907 ||| VBN
in  ||| S:907 E:910 ||| IN
both  ||| S:910 E:915 ||| DT
rat  ||| S:915 E:919 ||| NN
and  ||| S:919 E:923 ||| CC
human  ||| S:923 E:929 ||| JJ
placenta ||| S:929 E:937 ||| NN
.  ||| S:937 E:939 ||| .
In  ||| S:939 E:942 ||| IN
rat ||| S:942 E:945 ||| NN
,  ||| S:945 E:947 ||| ,
both  ||| S:947 E:952 ||| DT
placental  ||| S:952 E:962 ||| JJ
mRNA  ||| S:962 E:967 ||| JJ
and  ||| S:967 E:971 ||| CC
serum  ||| S:971 E:977 ||| JJ
levels  ||| S:977 E:984 ||| NNS
are  ||| S:984 E:988 ||| VBP
increased  ||| S:988 E:998 ||| VBN
throughout  ||| S:998 E:1009 ||| IN
pregnancy ||| S:1009 E:1018 ||| NN
,  ||| S:1018 E:1020 ||| ,
whereas  ||| S:1020 E:1028 ||| IN
their  ||| S:1028 E:1034 ||| PRP$
protein  ||| S:1034 E:1042 ||| NN
levels  ||| S:1042 E:1049 ||| NNS
are  ||| S:1049 E:1053 ||| VBP
significantly  ||| S:1053 E:1067 ||| RB
decreased  ||| S:1067 E:1077 ||| VBN
at  ||| S:1077 E:1080 ||| IN
the  ||| S:1080 E:1084 ||| DT
end  ||| S:1084 E:1088 ||| NN
of  ||| S:1088 E:1091 ||| IN
gestation ||| S:1091 E:1100 ||| NN
.  ||| S:1100 E:1102 ||| .
Serum  ||| S:1102 E:1108 ||| NNP
BDNF  ||| S:1108 E:1113 ||| NNP
levels  ||| S:1113 E:1120 ||| NNS
in  ||| S:1120 E:1123 ||| IN
pregnant  ||| S:1123 E:1132 ||| JJ
women  ||| S:1132 E:1138 ||| NNS
are  ||| S:1138 E:1142 ||| VBP
significantly  ||| S:1142 E:1156 ||| RB
lower  ||| S:1156 E:1162 ||| JJR
in  ||| S:1162 E:1165 ||| IN
the  ||| S:1165 E:1169 ||| DT
first  ||| S:1169 E:1175 ||| JJ
trimester  ||| S:1175 E:1185 ||| NN
when  ||| S:1185 E:1190 ||| WRB
compared  ||| S:1190 E:1199 ||| VBN
to  ||| S:1199 E:1202 ||| TO
the  ||| S:1202 E:1206 ||| DT
second  ||| S:1206 E:1213 ||| JJ
and  ||| S:1213 E:1217 ||| CC
third  ||| S:1217 E:1223 ||| JJ
trimester  ||| S:1223 E:1233 ||| NNS
( ||| S:1233 E:1234 ||| -LRB-
P  ||| S:1234 E:1236 ||| NNP
< ||| S:1236 E:1238 ||| SYM
0·0148 ||| S:1238 E:1244 ||| NNP
,  ||| S:1244 E:1246 ||| ,
P  ||| S:1246 E:1248 ||| NNP
< ||| S:1248 E:1250 ||| SYM
0·0012 ||| S:1250 E:1256 ||| NNP
,  ||| S:1256 E:1258 ||| ,
respectively ||| S:1258 E:1270 ||| RB
) ||| S:1270 E:1271 ||| -RRB-
.  ||| S:1271 E:1273 ||| .
Serum  ||| S:1273 E:1279 ||| NNP
BDNF  ||| S:1279 E:1284 ||| NNP
levels  ||| S:1284 E:1291 ||| NNS
were  ||| S:1291 E:1296 ||| VBD
negatively  ||| S:1296 E:1307 ||| RB
correlated  ||| S:1307 E:1318 ||| VBN
with  ||| S:1318 E:1323 ||| IN
gestational  ||| S:1323 E:1335 ||| JJ
age  ||| S:1335 E:1339 ||| NN
at  ||| S:1339 E:1342 ||| IN
birth  ||| S:1342 E:1348 ||| NN
and  ||| S:1348 E:1352 ||| CC
fasting  ||| S:1352 E:1360 ||| JJ
glucose  ||| S:1360 E:1368 ||| NN
levels ||| S:1368 E:1374 ||| NNS
.  ||| S:1374 E:1376 ||| .
Our  ||| S:1376 E:1380 ||| PRP$
findings  ||| S:1380 E:1389 ||| NNS
suggest  ||| S:1389 E:1397 ||| VBP
that  ||| S:1397 E:1402 ||| IN
both  ||| S:1402 E:1407 ||| DT
BDNF  ||| S:1407 E:1412 ||| NNP
and  ||| S:1412 E:1416 ||| CC
its  ||| S:1416 E:1420 ||| PRP$
receptor  ||| S:1420 E:1429 ||| NN
TrkB  ||| S:1429 E:1434 ||| NNS
are  ||| S:1434 E:1438 ||| VBP
expressed  ||| S:1438 E:1448 ||| VBN
in  ||| S:1448 E:1451 ||| IN
rodent  ||| S:1451 E:1458 ||| NN
and  ||| S:1458 E:1462 ||| CC
human  ||| S:1462 E:1468 ||| JJ
placenta  ||| S:1468 E:1477 ||| NNS
being  ||| S:1477 E:1483 ||| VBG
regulated  ||| S:1483 E:1493 ||| VBN
during  ||| S:1493 E:1500 ||| IN
pregnancy ||| S:1500 E:1509 ||| NN
.  ||| S:1509 E:1511 ||| .
Taken  ||| S:1511 E:1517 ||| VBN
together ||| S:1517 E:1525 ||| RB
,  ||| S:1525 E:1527 ||| ,
these  ||| S:1527 E:1533 ||| DT
findings  ||| S:1533 E:1542 ||| NNS
support  ||| S:1542 E:1550 ||| VBP
a  ||| S:1550 E:1552 ||| DT
role  ||| S:1552 E:1557 ||| NN
of  ||| S:1557 E:1560 ||| IN
BDNF  ||| S:1560 E:1565 ||| NNP
in  ||| S:1565 E:1568 ||| IN
the  ||| S:1568 E:1572 ||| DT
regulation  ||| S:1572 E:1583 ||| NN
of  ||| S:1583 E:1586 ||| IN
several  ||| S:1586 E:1594 ||| JJ
metabolic  ||| S:1594 E:1604 ||| JJ
functions  ||| S:1604 E:1614 ||| NNS
during  ||| S:1614 E:1621 ||| IN
pregnancy ||| S:1621 E:1630 ||| NN
.  ||| S:1630 E:1632 ||| .
